Douglas G. Franklin By Douglas G. Franklin MSAA President and CEO I have many new and exciting changes to announce for MSAA! These important initiatives have been in development for the past year, and appropriately for the spring season, have recently come to fruition. The first item I want to announce is our new mission […]
Read News ArticleAuthor: Sarah Masino
FDA Approves myBETAapp and BETACONNECT Navigator
A new mobile and cloud-based health technology offered by Bayer has been approved by the United States Food and Drug Administration (FDA) for individuals taking Betaseron for relapsing-remitting MS. On May 30, 2017, Bayer announced the approval of myBETAapp™ and the BETACONNECT Navigator™. With this software, in conjunction with Bluetooth technology, individuals using the electronic […]
Read News ArticleFirst Case of PML with Ocrevus is Reported
An individual with multiple sclerosis (MS) in Germany has developed progressive multifocal leukoencephalopathy (PML) following three years of treatment with Tysabri® (natalizumab) and one dose of Ocrevus™ (ocrelizumab). PML is a potentially fatal brain infection that can occur in people with a weakened immune system, which can result from taking an immunosuppressant. An increased risk […]
Read News ArticleMS Conversations Recognized as One of the Best MS Blogs of 2017 by Healthline
The Multiple Sclerosis Association of America’s MS Conversations blog is honored to be named one of Healthline’s Best Multiple Sclerosis Blogs of 2017. MSAA is pleased to have received this award for the third consecutive year. Recently, Healthline chose 23 blogs that actively work to educate, inspire, and empower readers with frequent updates and high-quality […]
Read News ArticleReferences
In this Section Main Article FDA-Approved Medications Experimental Medications New Directions in MS Research Closing Notes Approved Long-Term Treatments for MS (PDF) References 1 Kappos L, et al. “Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial.” Lancet. November 19, 2011; 378 (9805):1779-87. 2 Congress of the European Committee for Treatment and […]
Read News ArticleDiet and MS
In this Section Main Article FDA-Approved Medications Experimental Medications New Directions in MS Research Closing Notes Approved Long-Term Treatments for MS (PDF) References New Directions in MS Research: New Therapeutic Approaches Previous: The Microbiome and MS It is certainly intriguing to consider that dietary modification could be utilized in some way to impact the course […]
Read News ArticleThe Microbiome and MS
In this Section Main Article FDA-Approved Medications Experimental Medications New Directions in MS Research Closing Notes Approved Long-Term Treatments for MS (PDF) References New Directions in MS Research: New Therapeutic Approaches Previous: Genetic Studies | Next: Diet and MS Over the past decade, it has become clear that interactions between a person’s microbiome and their […]
Read News ArticleGenetic Studies
In this Section Main Article FDA-Approved Medications Experimental Medications New Directions in MS Research Closing Notes Approved Long-Term Treatments for MS (PDF) References New Directions in MS Research: New Therapeutic Approaches Previous: Biomarkers | Next: The Microbiome and MS A growing body of evidence has been found for the genetic component in MS. The studies […]
Read News ArticleBiomarkers
In this Section Main Article FDA-Approved Medications Experimental Medications New Directions in MS Researchx Closing Notes Approved Long-Term Treatments for MS (PDF) References New Directions in MS Research: New Therapeutic Approaches Previous: Stem Cells | Next: Genetic Studies In medicine, the term “biomarker” refers to anything that can be used as an indicator of a […]
Read News ArticleStem Cells
In this Section Main Article FDA-Approved Medications Experimental Medications New Directions in MS Research Closing Notes Approved Long-Term Treatments for MS (PDF) References New Directions in MS Research: New Therapeutic Approaches Previous: Vitamins and Electrolytes | Next: Biomarkers Based on encouraging results from a variety of studies, clinical trials are now starting to enroll people […]
Read News Article